Sort
21,453 grants matching “tuberculosis”
TUBERCULOSIS ELIMINATION AND LABORATORY
$473,779Utpala Bandy · Rhode Island State Dept Of Health · U52 · FY2007 · PS
Carbohydrate-based Antiinfective Agents
$473,750Chi-Huey Wong · Scripps Research Institute, The · R01 · FY2014 · AI
Carbohydrate-based Antiinfective Agents
$473,750Chi-Huey Wong · Scripps Research Institute, The · R01 · FY2012 · AI
Carbohydrate-based Antiinfective Agents
$473,750Chi-Huey Wong · Scripps Research Institute, The · R01 · FY2011 · AI
Sulfate Adenylation-Biochemistry & Enzymology
$473,737Thomas S. Leyh · Albert Einstein College Of Medicine · R01 · FY2010 · GM
A modular cell therapy platform for controlling immunological tolerance
$473,726Nathan Edward Reticker-Flynn · Stanford University · DP2 · FY2023 · AI
Center for Vulnerable Populations Research
$473,654Deborah Koniak-Griffin · University Of California Los Angeles · P30 · FY2007 · NR
Infectious Disease and Basic Microbiological Mechanisms
$473,654Marcia B Goldberg · Massachusetts General Hospital · T32 · FY2015 · AI
Modeling Core
$473,646Nitin S Baliga · Seattle Biomedical Research Institute · U19 · FY2016 · AI
The Function of Host-derived Extracellular Vesicles in Trafficking of Bacterial Antigens to Stimulate the Antibacterial Immune Response
$473,541Mariola Jadwiga Ferraro · University Of Florida · R01 · FY2025 · AI
A modular cell therapy platform for controlling immunological tolerance
$473,515Nathan Edward Reticker-Flynn · Stanford University · DP2 · FY2024 · AI
A modular cell therapy platform for controlling immunological tolerance
$473,515Nathan Edward Reticker-Flynn · Stanford University · DP2 · FY2025 · AI
Decision Making for Social Distancing
$473,452Samuel J Simmens · George Washington University · R15 · FY2014 · AI
Host Determinants of Tuberculosis Susceptibility
$473,337Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · P01 · FY2020 · AI
Hearing impairment in HIV-infected and HIV/TB-coinfected individuals in Tanzania
$473,036Jay C Buckey · Dartmouth College · R01 · FY2014 · DC
Using Community Participation to Improve the Health System in South India
$473,020Kaivan Munshi · Brown University · R01 · FY2010 · HD
Autophagy proteins in the immune response to Mycobacterium tuberculosis infection
$472,998Christina Leigh Stallings · Washington University · R01 · FY2023 · AI
Autophagy proteins in the immune response to Mycobacterium tuberculosis infection
$472,998Christina Leigh Stallings · Washington University · R01 · FY2022 · AI
Development of nanoparticulate solution for cancer treatment by breakup of tumor extracellular hydroxyapatite: a new paradigm
$472,960Mohammed Noor Tantawy · Vanderbilt University Medical Center · R21 · FY2021 · CA
Pharmacology & ImmunoPathology (PIP) Core
$472,717Veronique Dartois · Weill Medical Coll Of Cornell Univ · U19 · FY2022 · AI
Control of Bacterial Toxins by Viruses and Plasmids
$472,500University Of Colorado Denver · R37 · FY2005 · AI
Clade-specific regulation of HIV-1 by M tuberculosis
$472,500Immune Disease Institute, Inc. · R21 · FY2004 · AI
Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t
$472,301Neil Desai · Aadi, Llc · R42 · FY2012 · CA
Chemical Mycobateriology
$472,276Carolyn R Bertozzi · Stanford University · R37 · FY2022 · AI
Multidisciplinary HIV Training Program
$472,274Daniel R Kuritzkes · Brigham And Women'S Hospital · T32 · FY2025 · AI